Freedom of Information Request 0325 2019/20
I have a Freedom of Information request about Cancer treatments with your organisation.
1 – How many melanoma patients undergoing treatment are BRAF+ ?
1a -In the past 3 months, how many melanoma patients were treated with the following:
Bevacizumab
Cobimetinib
Dabrafenib
Dabrafenib AND trametinib
Dacarbazine
Encorafenib AND binimetinib
Ipilimumab
Ipilimumab AND Nivolumab
Nivolumab
Pembrolizumab
Trametinib
Vemurafenib
Vemurafenib AND Cobimetinib
Other active systemic anti-cancer therapy
Palliative care
1b – In the past 3 months how many patients were seen who had stage III resectable melanoma
1c – Of all stage III patients seen, how many received a complete resection ?
1d – Of all stage III patients seen, how many were stage III a ?
2 – In the past 3 months, how many Squamous Cell Non-small cell lung cancer (SqNSCLC) patients were treated with:
Afatinib
Atezolizumab monotherapy
Bevacizumab
Docetaxel monotherapy
Durvalumab
Erlotinib
Gemcitabine
Necitumumab
Nivolumab
Paclitaxel
Pembrolizumab monotherapy
Pembrolizumab chemo in combination
Pemetrexed
Ramucirumab
Vinorelbine and cisplatin / carboplatin
Other active systemic anti-cancer therapy [please state]
Palliative care only
3 – In the past 3 months, how many Non Squamous Cell Non-small cell lung cancer (Non SqNSCLC) patients were treated with:
Afatinib
Alectinib
Atezolizumab mono
Atezolizumab + bevacizumab + carboplatin + paclitaxel
Bevacizumab
Brigatinib
Ceritinib
Crizotinib
Dacomitinib
Docetaxel monotherapy
Erlotinib
Gefitinib
Nintedanib with docetaxel
Nivolumab
Osimertinib
Paclitaxel
Pembrolizumab monotherapy
Pembrolizumab chemo in combination
Pemetrexed with carboplatin
Pemetrexed with cisplatin
Ramucirumab
Other active systemic anti-cancer therapy [please state]
Palliative care only
4 – In the past 3 months, how many Urothelial cancer patients were treated with;
Atezolizumab
Carboplatinum in combination with another agent
Carboplatinum single agent
Cisplatinum in combination with another agent
Cisplatinum single agent
Nivolumab
Pembrolizumab
Any other chemo regimen without cisplatinum or carboplatinum
Other active systemic anti-cancer therapy [please state]
Palliative care only